Emerging SARS-CoV-2 mutations L452R & Y453F evade cellular immunity

emerging sars cov 2 mutations l452r y453f evade cellular immunity

Sumary of Emerging SARS-CoV-2 mutations L452R & Y453F evade cellular immunity:

  • The coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally, with the total number of cases reaching over 191 million.
  • Despite vaccination efforts, many SARS-CoV-2 variants with naturally acquired mutations have emerged.
  • Researchers at the Kumamoto University and Weizmann Institute of Science found that the L452R mutation of the SARS-CoV-2 spike protein, which is common to two mutant strains, the Epsilon and Delta, can evade cellular immunity through the human leukocyte (HLA) A24 and can increase viral infectivity.
  • Microbe, also showed emerging mutations L452R and Y453F in the SARS-CoV-2 spike receptor-binding motif evade (HLA) A24-restricted cellular immunity.
  • Meanwhile, the L452R enhances spike stability, viral fusogenicity, and viral infectivity.
  • Hence, the findings suggest that HLA-restricted cellular immunity potentially affects the evolution of viral phenotypes.
  • SARS-CoV-2 mutants Though vaccination efforts have commenced in most countries and over 3.71 billion doses have already been administered, the threat of COVID-19 is far from over.
  • The first reported and well-studied mutant contains a D614G substitution in the spike (S) protein.

Want to know more click here go to source.

From -

Generic selectors
Exact matches only
Search in title
Search in content

Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.